The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


HISTEK



Fannin LimitedPA1457/012/002

Main Information

Trade NameHISTEK
Active SubstancesCETIRIZINE DIHYDROCHLORIDE
Dosage FormFilm Coated Tablet
Licence HolderFannin Limited
Licence NumberPA1457/012/002

Group Information

ATC CodeR06AE07 cetirizine

Status

License statusWithdrawn
Withdrawn Date31/01/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot Marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back